The next-generation platform for multiplex diagnostics.
We translate multiplex real-time PCR technology into the clinical laboratory workflow. A single thermal protocol, a single standard, a consistent user experience across the kit family — integrated digital diagnostic flow with companion software.
Up to 7 targets per tube · ~50 minute cycle · sigmoid-curve algorithm with semi-quantitative Ct grading · single thermal protocol shared by the entire kit family. The clinician sees a categorised result, not just positive/negative.
Detailed technology page is being prepared. For specifications, please refer to each product's IFU on the Documents page.
All kits run on the same Uniqplex platform; the clinician selects a category based on the answer being sought in the sample.
COVID-19, Influenza, RSV, Adenovirus and broad respiratory panels.
6 kits
Diarrhea pathogens and C. difficile detection panels.
2 kits
STI panel, HPV genotyping family, HSV quantification.
6 kits
Meningitis and encephalitis panel — bacteria, viruses, fungi included.
1 kit
EBV, BKV, JCV, Parvovirus B19 — transplant and immunosuppressed patients.
4 kits
Aspergillus, Candida, Pneumocystis jirovecii detection.
3 kits
Streptococcus pyogenes detection and monitoring.
1 kit
Next-generation sequencing kits and software — under R&D.
Coming Soon
Absolute quantification kits and analysis software — under R&D.
Coming Soon
The Uniqplex kit family is in the (EU) 2017/746 IVDR conformity assessment process. A written agreement has been signed with SGS Belgium NV (Notified Body NB 1639) per IVDR Annex VII Section 4.3, and the formal application has been completed.
Under (EU) 2024/1860 transition provisions, kit supply and clinical use continue uninterrupted. Class B transition: 31 December 2029 · Class C transition: 31 December 2028.
Reference: CLNB1639 · TR/IST/22215599 · 30 March 2026